Reports for FRESENIUS KABI CANADA LTD
Company Name
FRESENIUS KABI CANADA LTD
Totals |
||
Shortage reports |
328 |
|
| Actual shortage: | 10 (3%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 5 (2%) | |
| Resolved: | 312 (95%) | |
Discontinuation Reports |
2 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
50 (15%) |
|
Overdue reports |
4 (36%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| POTASSIUM PHOSPHATES INJECTION, USP | 236MG 224MG | SOLUTION | Actual shortage | 2017-05-30 | 2024-12-02 | 11547 |
| POTASSIUM PHOSPHATES INJECTION, USP | 236MG 224MG | SOLUTION | Actual shortage | 2024-10-22 | 2024-12-02 | 240890 |
| SODIUM ACETATE INJECTION, USP | 328MG | SOLUTION | Actual shortage | 2022-09-01 | 2024-09-24 | 168505 |
| SODIUM ACETATE INJECTION, USP | 328MG | SOLUTION | Actual shortage | 2023-06-01 | 2024-09-24 | 193516 |
| PENICILLIN G SODIUM FOR INJECTION, USP | 5000000UNIT | POWDER FOR SOLUTION | Actual shortage | 2024-09-27 | 2024-09-27 | 238762 |
| TOBRAMYCIN INJECTION | 40MG | SOLUTION | Actual shortage | 2022-07-07 | 2022-10-03 | 164261 |
| MESNA FOR INJECTION | 100MG | SOLUTION | Actual shortage | 2023-08-03 | 2024-01-09 | 201038 |
| 0.9% SODIUM CHLORIDE INJECTION | 900MG | SOLUTION SOLUTION | Actual shortage | 2024-10-25 | 2024-10-29 | 241158 |
| SODIUM BICARBONATE INJECTION, USP | 42MG | SOLUTION | Actual shortage | 2023-03-10 | 2024-04-05 | 186632 |
| MORPHINE SULFATE INJECTION, USP | 2MG | SOLUTION | Actual shortage | 2024-11-20 | 2024-12-02 | 243494 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Anticipated shortage | 2024-11-21 | 2024-11-21 | 243515 |
| MIDAZOLAM INJECTION | 5MG | LIQUID | Avoided shortage | 2022-04-28 | 2022-06-01 | 159557 |
| HALOPERIDOL INJECTION, USP | 5MG | SOLUTION | Avoided shortage | 2021-02-05 | 2021-08-19 | 133505 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Avoided shortage | 2017-06-14 | 2020-01-16 | 12782 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Avoided shortage | 2022-04-13 | 2022-07-15 | 158783 |
| SODIUM BICARBONATE INJECTION, USP | 84MG | SOLUTION | Avoided shortage | 2022-04-13 | 2022-06-08 | 158795 |
| CEFTAZIDIME FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2020-06-25 | 2020-08-05 | 118930 |
| CEFTAZIDIME FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2022-04-13 | 2022-05-24 | 158756 |
| CEFTAZIDIME FOR INJECTION, USP | 6G | POWDER FOR SOLUTION | Resolved | 2022-04-13 | 2022-05-24 | 158759 |
| CEFTAZIDIME FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Resolved | 2021-12-10 | 2022-05-24 | 150950 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SODIUM BICARBONATE INJECTION, USP | 42MG | SOLUTION | Discontinued | 2024-10-03 | 2024-10-03 | 239180 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Discontinued | 2024-08-13 | 2024-08-20 | 235203 |
Showing 1 to 2 of 2